Ben Casavant
Ben Casavant is co-founder and CEO at Tasso, Inc., where he leads the company.
Tasso, Inc. obtains Health Canada license and EU approvals to sell Tasso Mini in Canada, Italy, and Spain
Tasso, Inc. received Health Canada licensing and additional EU approvals allowing its Tasso Mini blood collection device to be sold in Canada, Italy, and Spain, expanding availability beyond its existing U.S. FDA 510(k) clearance and CE Marking. The Tasso Mini is designed for gentle, virtually painless sampling for sensitive or repeat-use patients and now matches the international availability of Tasso’s flagship Tasso+® device.
Tasso Ships One Millionth At‑Home Diagnostic Device, CEO Ben Casavant Celebrates Milestone
Tasso shipped its one millionth at-home diagnostic device, marking a milestone toward making healthcare more accessible and enabling patients to access trials and testing they previously couldn’t. CEO Ben Casavant and the team thank employees, partners, investors, and patients and say they’re focused on continuing growth toward the next million.
Tasso Launches Tasso Care® for Prescreening to Streamline At‑Home Clinical Trial Screening
Tasso launched Tasso Care® for Prescreening, a full-service, at-home blood collection and analysis platform that streamlines clinical trial prescreening to boost enrollment, diversity, and sample quality while expanding panels for multiple therapeutic areas.
Tasso, Inc. completes SOC 2 Type 2 audit with no exceptions, validating secure management of patient data
Tasso, Inc. completed a SOC 2 Type 2 audit with no exceptions across all five Trust Services Criteria, confirming its ability to securely manage patient and client data and reinforcing its commitment to privacy and security.
Tasso, Inc. grows in 2023 with Aptar, CardioRenal and UBC partnerships and earns MDSAP certification
Tasso, Inc. reports strong 2023 growth driven by new partnerships (Aptar Digital Health, CardioRenal, United BioSource/UBC) and rising demand for its at‑home, patient‑centric blood collection solutions, positioning the company for expanded use in decentralized clinical trials and home diagnostics. The company also earned MDSAP certification, enabling regulatory access to Australia, Canada, the U.S., and facilitating entry into markets like Brazil and Japan.
Organizations
-
Tasso Executive Officer, Director, Promoter 2020–present, Co-founder 2011–present · current
Education
-
University of Wisconsin-Madison PhD, Biomedical Engineering · 2009–2013
-
Wisconsin School of Business Minor, Entrepreneurship · 2009–2012
-
University of California, Berkeley BS, Bioengineering · 2005–2009
